1,736 Shares in The Procter & Gamble Company (NYSE:PG) Bought by Opinicus Capital Inc.

Opinicus Capital Inc. bought a new position in shares of The Procter & Gamble Company (NYSE:PGFree Report) during the first quarter, HoldingsChannel.com reports. The institutional investor bought 1,736 shares of the company’s stock, valued at approximately $282,000.

A number of other institutional investors have also added to or reduced their stakes in PG. HighPoint Advisor Group LLC acquired a new position in shares of Procter & Gamble in the fourth quarter valued at $17,696,000. Dfpg Investments LLC boosted its position in shares of Procter & Gamble by 1.7% in the fourth quarter. Dfpg Investments LLC now owns 24,892 shares of the company’s stock valued at $3,680,000 after acquiring an additional 424 shares during the period. Campbell Wealth Management boosted its position in shares of Procter & Gamble by 13.1% in the fourth quarter. Campbell Wealth Management now owns 1,988 shares of the company’s stock valued at $291,000 after acquiring an additional 231 shares during the period. Herold Advisors Inc. boosted its position in shares of Procter & Gamble by 2.2% in the fourth quarter. Herold Advisors Inc. now owns 26,592 shares of the company’s stock valued at $3,897,000 after acquiring an additional 581 shares during the period. Finally, Metis Global Partners LLC boosted its position in shares of Procter & Gamble by 15.7% in the fourth quarter. Metis Global Partners LLC now owns 115,039 shares of the company’s stock valued at $16,858,000 after acquiring an additional 15,599 shares during the period. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Procter & Gamble news, insider Balaji Purushothaman sold 28,369 shares of the stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the completion of the sale, the insider now owns 11,507 shares of the company’s stock, valued at approximately $1,858,265.43. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Procter & Gamble news, insider Balaji Purushothaman sold 28,369 shares of the stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the completion of the sale, the insider now owns 11,507 shares of the company’s stock, valued at approximately $1,858,265.43. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Gary A. Coombe sold 21,388 shares of the firm’s stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $164.98, for a total transaction of $3,528,592.24. Following the sale, the chief executive officer now directly owns 36,854 shares of the company’s stock, valued at approximately $6,080,172.92. The disclosure for this sale can be found here. Insiders sold 154,544 shares of company stock valued at $25,413,051 over the last quarter. 0.17% of the stock is owned by company insiders.

Procter & Gamble Price Performance

Shares of PG stock traded down $1.70 on Friday, reaching $164.92. The company had a trading volume of 9,253,317 shares, compared to its average volume of 6,088,934. The business’s 50-day moving average is $165.60 and its 200 day moving average is $158.73. The Procter & Gamble Company has a one year low of $141.45 and a one year high of $169.41. The company has a quick ratio of 0.48, a current ratio of 0.69 and a debt-to-equity ratio of 0.49. The stock has a market capitalization of $389.23 billion, a PE ratio of 26.95, a price-to-earnings-growth ratio of 3.38 and a beta of 0.42.

Procter & Gamble (NYSE:PGGet Free Report) last released its quarterly earnings data on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.10. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The company had revenue of $20.20 billion during the quarter, compared to the consensus estimate of $20.43 billion. During the same quarter in the prior year, the firm posted $1.37 earnings per share. The firm’s revenue was up .6% compared to the same quarter last year. Equities research analysts forecast that The Procter & Gamble Company will post 6.55 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th were paid a $1.0065 dividend. The ex-dividend date was Thursday, April 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.44%. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s dividend payout ratio is currently 65.85%.

Analyst Ratings Changes

PG has been the subject of a number of recent research reports. Truist Financial raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and boosted their target price for the company from $160.00 to $175.00 in a research report on Monday, March 11th. StockNews.com raised shares of Procter & Gamble from a “hold” rating to a “buy” rating in a research report on Tuesday. Barclays upped their price objective on shares of Procter & Gamble from $168.00 to $170.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 23rd. The Goldman Sachs Group initiated coverage on shares of Procter & Gamble in a research report on Friday, March 1st. They set a “neutral” rating and a $168.00 price objective for the company. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on shares of Procter & Gamble from $172.00 to $171.00 and set a “buy” rating for the company in a research report on Monday, April 22nd. Six analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and a consensus price target of $170.72.

Get Our Latest Report on PG

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.